(19)
(11) EP 4 816 400 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24817609.1

(22) Date of filing: 02.12.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
C07K 14/715(2006.01)
 A61P 17/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2866; C07K 2317/76; C07K 2317/565; C07K 14/7155; A61P 17/04; A61P 37/00; C07K 16/28
(86) International application number:
PCT/EP2024/084368
(87) International publication number:
WO 2025/114614 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.11.2023 EP 23307106

(71) Applicant: Vetoquinol SA
70200 Lure (FR)

(72) Inventor:
  • LEGER, Olivier
    74800 SAINT SIXT (FR)

(74) Representative: Regimbeau 
20, rue de Chazelles
75847 Paris Cedex 17
75847 Paris Cedex 17 (FR)

   


(54) ANTI-CANINE INTERLEUKINE-4-RECEPTOR ALPHA (IL-4R-ALPHA) ANTIBODIES AND THE USES THEREOF